AbbVie invests heavily in physician-directed marketing
In 2023, AbbVie, a well-known pharmaceutical company, made a prominent move in the industry by investing an estimated $145.7 million on physician-directed marketing. The company, famous for creating the successful anti-inflammatory drug Humira, showed its aggressive marketing strategies to fortify its standing in the ever-competitive pharmaceutical field. Humira, a worldwide best-selling drug, transformed the treatment … Read more